...
首页> 外文期刊>The Indian journal of tuberculosis >RANDOMIZED, DOUBLE-BLIND STUDY ON ROLE OF LOW LEVEL NITROGEN LASER THERAPY IN TREATMENT FAILURE TUBERCULAR LYMPHADENOPATHY,SINUSES AND COLD ABSCESS
【24h】

RANDOMIZED, DOUBLE-BLIND STUDY ON ROLE OF LOW LEVEL NITROGEN LASER THERAPY IN TREATMENT FAILURE TUBERCULAR LYMPHADENOPATHY,SINUSES AND COLD ABSCESS

机译:低水平氮激光治疗在治疗失败性肾小管淋巴结肿大,鼻窦炎和冷痛中的作用的随机双盲研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Effectiveness of low level nitrogen laser therapy along with antitubercular treatment (ATT) in cases of treatment failure and drug resistant tubercular lymphadenopathy, sinuses and cold abscess. Methods: In a double-blind randomized controlled trial ofLLLT,104 patients assigned to either the low level nitrogen laser therapy along with ATT ( LLLT group) (n =54) or ATT only(Chemotherapy group)(n=50). Both groups were treated two times per week for five weeks. Those in the treatment group received pulse nitrogen laser with a pulse duration of seven nanosecond, wave length 337 nanometer and average power output of 5 mW whereas those in the control group were treated with sham laser. The primary outcome measure was bacteriological conversion and the secondary outcome measures were decrease in size of lesion and the clinical improvement. Results: Acid Fast Bacilli (AFB) smear, AFB culture and Polymerase Chain Reaction(PCR) conversion rate at five weeks (after 10 sittings of laser) were 49.15%( Fishers P exact test-p= 0.015), 60%, 44.44% (Fishers P exact test-p= 0.048 ) in LLLT group as compared to 11.86%,20%, 17.77% in chemotherapy group. Average percentage reduction in the size of gland at 5 weeks was 70.67% (p value 0.01) as compared to 54.81 in chemotherapy group. Average time taken for closure of sinuses was 11.03 weeks in LLLT group as compared to 26 weeks in chemotherapy group. The follow up was conducted for two years. Conclusion: Low level nitrogen laser therapy can be used as an adjunctive therapy along with antitubercular drugs in cases not responding and drug resistant tubercular lymphadenopathy, sinuses and cold abscess.
机译:背景:在治疗失败和耐药结核性淋巴结病,鼻窦和脓肿的情况下,低剂量氮激光疗法与抗结核治疗(ATT)的有效性。方法:在一项LLLT的双盲随机对照试验中,有104例患者接受了ATT的低水平氮激光治疗(LLLT组)(n = 54)或仅接受ATT(化学疗法组)(n = 50)。两组每周治疗两次,共五周。治疗组接受脉冲氮激光,脉冲持续时间为7纳秒,波长为337纳米,平均功率输出为5 mW,而对照组则接受假激光治疗。主要结局指标是细菌学转化,次要结局指标是病灶缩小和临床改善。结果:五周(经过10次激光治疗)的耐酸杆菌(AFB)涂片,AFB培养和聚合酶链反应(PCR)转化率分别为49.15%(Fishers P精确检验-p = 0.015),60%,44.44% LLLT组(Fishers P精确检验-p = 0.048),而化疗组为11.86%,20%,17.77%。与化疗组的54.81相比,第5周的腺体平均缩小百分比为70.67%(p值0.01)。 LLLT组闭合鼻窦的平均时间为11.03周,而化疗组为26周。随访进行了两年。结论:对于无反应和耐药结核性淋巴结病,鼻窦炎和脓肿的患者,低剂量氮激光治疗可与抗结核药物一起作为辅助治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号